发明名称 THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDER
摘要 Object of the present invention is to search a novel pharmaceutical use of 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy) benzyl] thiazolidine-2, 4-dione being a condensed heterocyclic compound, or a salt thereof. 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy) benzyl] thiazolidine-2, 4-dione or a salt thereof can exert an excellent effect to promote healing in a dry eye model, and is useful as a therapeutic agent for keratoconjunctival disorders such as dry eyes, corneal ulcer, keratitis, conjunctivitis, superficial punctate keratopathy, corneal epithelial defects, conjunctival epithelial defects, keratoconjunctivitis sicca, superior limbic keratoconjunctivitis and filamentary keratitis.
申请公布号 KR101154175(B1) 申请公布日期 2012.06.14
申请号 KR20067009936 申请日期 2004.10.22
申请人 发明人
分类号 A61K31/427;C07D417/12;A61P27/00;A61P27/04 主分类号 A61K31/427
代理机构 代理人
主权项
地址